Patent details

Basic Information

Publication number:

EP3423059

PCT Application Number:

EP2017054435

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177073129

PCT Publication Number:

WO2017148837

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

French Title of Invention:

COMPOSITIONS DE FORMES GALÉNIQUES COMPRENANT UN INHIBITEUR DE LA TYROSINE KINASE DE BRUTON

German Title of Invention:

DOSIERUNGSFORMZUSAMMENSETZUNGEN MIT EINEM HEMMER DER BRUTON-TYROSINKINASE

SPC Number:

Dates

Filing date:

27/02/2017

Grant date:

23/03/2022

EP Publication Date:

09/01/2019

PCT Publication Date:

08/09/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/03/2022

EP B1 Publication Date:

23/03/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/02/2023

Expiration date:

27/02/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/03/2022

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacher Strasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

KOU, Dawen

Address:

United States (US)

2

Name:

MAO, Chen

Address:

United States (US)

3

Name:

CHIANG, Po-Chang

Address:

United States (US)

Priority

Priority Number:

201662301373 P

Priority Date:

29/02/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4985; A61K 47/12; A61K 9/14; A61K 9/20; A61P 35/00; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

202212

Publication date:

23/03/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages